EPIGRAL LIMITED (EPIGRAL) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals.[1]

EPIGRALUpdated 31 Aug 2026, 20:22

Epigral Limited

Market Cap

₹5,195Cr.

Current Price

₹1,203

High / Low

₹1,890/806

Stock P/E

19.1

ROE15.8%
ROCE15.3%
Book Value₹515
Face Value₹10.0
Dividend Yield0.42%

About

Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days4341474046526028343360
Inventory Days75594558645174699010589
Days Payable3137515262694236635066
Cash Conversion Cycle8663424648349261618883
Working Capital Days434019-27-76-92-26-41-542616
ROCE %18%37%36%15%16%29%32%17%25%15%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 20:22


Designed & Shipped by Harshit Bansal